DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
종목 코드 DRIO
회사 이름DarioHealth Corp
상장일Mar 08, 2013
CEOMr. Erez Raphael
직원 수196
유형Ordinary Share
회계 연도 종료Mar 08
주소322 W 57Th St. #33B
도시NEW YORK
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호10019
전화16466654667
웹사이트https://shop.mydario.com/
종목 코드 DRIO
상장일Mar 08, 2013
CEOMr. Erez Raphael
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음